TY - JOUR
T1 - Activatable Porphyrin-Based Sensors, Photosensitizers and Combination Therapeutics
AU - Bandyopadhyay, Suritra
AU - Forzano, Joseph A.
AU - Dirak, Musa
AU - Chan, Jefferson
N1 - S.B. is thankful for the support from the Arnold and Mabel Beckman Foundation for his Beckman Graduate Fellowship. M.D. is thankful for support via the International Research Fellowship Programme for PhD Students ( TUBITAK 2214-A). TOC artwork created with Biorender.com .
PY - 2025/1/27
Y1 - 2025/1/27
N2 - Porphyrins, known as the “pigments of life”, have evolved from their natural roles into versatile tools for biomedical applications. The development of activatable porphyrins has significantly expanded their utility, enabling precise responses to a carefully selected target analyte. These advances have broadened their use in imaging, diagnosis, and therapy. These capabilities are driven by activity-based sensing (ABS), which enhances the selectivity and sensitivity to various disease biomarkers. However, their design and implementation are intrinsically complex. This perspective provides an easy-to-follow roadmap that details how such molecules can be developed. Furthermore, we highlight recent progress in ABS-modified porphyrins, focusing on how specific modifications achieve these remarkable properties across various biomedical platforms. The ongoing evolution of activatable porphyrins holds great promise for the development of sophisticated, responsive systems, offering more effective diagnostic and therapeutic tools.
AB - Porphyrins, known as the “pigments of life”, have evolved from their natural roles into versatile tools for biomedical applications. The development of activatable porphyrins has significantly expanded their utility, enabling precise responses to a carefully selected target analyte. These advances have broadened their use in imaging, diagnosis, and therapy. These capabilities are driven by activity-based sensing (ABS), which enhances the selectivity and sensitivity to various disease biomarkers. However, their design and implementation are intrinsically complex. This perspective provides an easy-to-follow roadmap that details how such molecules can be developed. Furthermore, we highlight recent progress in ABS-modified porphyrins, focusing on how specific modifications achieve these remarkable properties across various biomedical platforms. The ongoing evolution of activatable porphyrins holds great promise for the development of sophisticated, responsive systems, offering more effective diagnostic and therapeutic tools.
KW - activity-based sensing
KW - biomedical applications
KW - diagnostic tools
KW - porphyrins
KW - therapeutic tools
UR - http://www.scopus.com/inward/record.url?scp=85215575054&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215575054&partnerID=8YFLogxK
U2 - 10.1021/jacsau.4c01108
DO - 10.1021/jacsau.4c01108
M3 - Review article
C2 - 39886600
AN - SCOPUS:85215575054
SN - 2691-3704
VL - 5
SP - 42
EP - 54
JO - JACS Au
JF - JACS Au
IS - 1
ER -